Your browser does not support JavaScript!
Logo de FierceBiotech

FierceBiotech Source d'actualité

Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 heures

IBM tech explains why some cancer cells die in response to treatment and others don’t

Hier à 19:24
Several cancer drugs work by promoting “apoptosis,” or programmed cell death. Researchers at Mount Sinai, working with IBM, found a link between responses to those treatments and mitochondria, the...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 15:43

Epic Sciences nets Myriad’s cancer president to serve as its CEO

Hier à 19:23
Liquid biopsy developer Epic Sciences has brought on Myriad Genetics’ oncology chief, Lloyd Sanders, to be its new president and CEO....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 14:05

Agios blood cancer drug lead jumps ship to Aprea Therapeutics

Hier à 19:24
Swedish p53 cancer biotech Aprea Therapeutics has nabbed former Agios senior medical director Eyal Attar as its senior vice president and chief medical officer....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 11:52

Roche-backed Arch Oncology gets off $50M round for anti-CD47 cancer work

Hier à 19:24
Just weeks after kick-starting its phase 1 test, Arch Oncology has gathered $50 million in financing to help see its immuno-oncology asset through the clinic....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 07:36

Thermo Fisher to buy viral vector maker Brammer Bio for $1.7B

Hier à 19:24
Thermo Fisher Scientific has moved to acquire viral vector developer and manufacturer Brammer Bio for $1.7 billion in cash, giving it a new foothold in the cell and gene therapy market....
www.fiercebiotech.com
Charger plus d'actualités

Informations juridiques

SIREN / SIRET USA Washington, DC

Adresse

Washington DC USA- Washington, DC Etats-Unis

Equipes

Je travaille dans cette entreprise